How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,267 results for

Long-Acting Reversible Contraception

by
...
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

41. Obstetrics-gynecology resident long-acting reversible contraception training: the role of resident and program characteristics. Full Text available with Trip Pro

Obstetrics-gynecology resident long-acting reversible contraception training: the role of resident and program characteristics. Obstetrics-gynecology residents should graduate with competence in comprehensive contraceptive care, including long-acting reversible contraception. Lack of hands-on training and deficits in provider education are barriers to long-acting reversible contraception access. Identifying the number of long-acting reversible contraception insertions performed by obstetrics (...) -gynecology residents could provide insight into the depth and breadth of long-acting reversible contraception training available to obstetrics-gynecology residents in Accreditation Council for Graduate Medical Education-accredited residency programs.Our study investigates long-acting reversible contraception-specific training in obstetrics-gynecology residency programs across the United States, including the self-reported number of long-acting reversible contraception insertions per resident

2020 American Journal of Obstetrics and Gynecology

42. Coverage of immediate postpartum long-acting reversible contraception has improved birth intervals for at-risk populations. Full Text available with Trip Pro

Coverage of immediate postpartum long-acting reversible contraception has improved birth intervals for at-risk populations. In 2012, South Carolina revised the Medicaid policy to cover reimbursement for immediate postpartum long-acting reversible contraception. Immediate postpartum long-acting reversible contraception may improve health outcomes for populations at risk with a subsequent short-interval pregnancy.We examined the impact of the Medicaid policy change on the initiation of long (...) -acting and reversible contraception (immediate postpartum and postpartum) within key populations. We determined whether immediate postpartum long-acting and reversible contraception use varied by adequate prenatal care (>7 visits), metropolitan location, and medical comorbidities. We also tested the association of immediate postpartum and postpartum long-acting, reversible contraception on interpregnancy interval of less than 18 months.We conducted a historical cohort study of live births among

2020 American Journal of Obstetrics and Gynecology

43. Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont. (Abstract)

Perceptions of long-acting reversible contraception among women receiving medication for opioid use disorder in Vermont. To evaluate perceptions of long-acting reversible contraceptives (LARC) among women receiving medication for opioid use disorder.Cross-sectional survey of 200 women receiving medication for opioid use disorder in Vermont.A considerable proportion of women receiving medication for opioid use disorder in Vermont reported previous use of an IUD (40%) and/or a subdermal (...) contraceptive implant (16%); the majority of prior LARC users were satisfied with their IUD (68%) or their implant (74%). Of the 38% of participants who had never considered IUD use, 85% percent (64/75) said that they knew nothing or only a little about IUDs. Of the 61% of participants who had never considered an implant, 81% percent (98/121) said that they knew nothing or only a little about the contraceptive method. The most commonly reported reasons for a lack of interest in the IUD and/or implant were

2020 Contraception

44. Predictors of choosing long-acting reversible contraceptive methods when provided free-of-charge - A prospective cohort study in Finland. Full Text available with Trip Pro

Predictors of choosing long-acting reversible contraceptive methods when provided free-of-charge - A prospective cohort study in Finland. To identify factors associated with choosing long-acting reversible contraception (LARC) (intrauterine device or contraceptive implant), when provided free-of-charge.This register-based cohort study comprises all women living in the city of Vantaa in the Helsinki metropolitan area during 2013-2014, with information on LARC initiations retrieved from (...) electronic health records. Since January 2013, women in Vantaa can receive their first LARC method free-of-charge at public contraceptive clinics. We performed multivariable regression to assess seven predictors based on literature and four predictors based on gynecological history for association with choosing LARC in this population.In 2013-2014, 9669 women entitled to a free-of-charge method visited a public clinic and 2035 (21.0%) women initiated LARC. Factors most associated with LARC initiation

2020 Contraception

45. Cohort study: Oral contraceptives do not appear to present long-term cancer harms and may even provide protection against some cancers

prescribe combined oral contraceptive (COCs) and counsel patients about COCs are in a position to ensure balanced discussion as they improve patient knowledge of known benefits and risks. Prescribers presenting health teaching should have an equal focus on the benefits and risks. Future research should include side-by-side comparisons of COCs and other types of fertility control (ie, long-acting reversible contraceptives and/or vaginal rings) to provide women with the evidence needed to make informed (...) Cohort study: Oral contraceptives do not appear to present long-term cancer harms and may even provide protection against some cancers Oral contraceptives do not appear to present long-term cancer harms and may even provide protection against some cancers | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log

2018 Evidence-Based Nursing

46. Influence of military contraceptive policy changes on contraception use and childbirth rates among new recruits. (Abstract)

training implemented in January 2015, and a Marine Corps policy change restricting contraceptive access during basic training implemented in January 2016 on the following: contraception use (pills, patches, rings, injectable, implantable, and intrauterine) at 6 months, long-acting reversible contraception use at 6 months, and childbirth prior to 24 months after service entry. We used logistic and Cox regression models, adjusted for age group, to compare outcomes of women in the Navy and Marine Corps (...) -1.41) and long-acting reversible contraception use 11.0% to 22.7% (odds ratio, 1.78; 95% confidence interval, 1.50-2.08). However, this policy change was not associated with a decline in childbirth rates among sailors (7.5% versus 6.1%) relative to the change among women in the Army and Air Force over the same time period (interaction term hazard ratio, 0.90; 95% confidence interval, 0.79-1.03). The January 2016 Marine Corps policy change decreased contraception use (29.6% to 24.4%; odds ratio

2020 American Journal of Obstetrics and Gynecology

47. Twelve-month contraceptive continuation among women initiating short- and long-acting reversible contraceptives in North Kivu, Democratic Republic of the Congo. Full Text available with Trip Pro

Twelve-month contraceptive continuation among women initiating short- and long-acting reversible contraceptives in North Kivu, Democratic Republic of the Congo. Despite the inclusion of sexual and reproductive health (SRH) services in the minimum standards of health care in humanitarian settings, access to SRH services, and especially to contraception, is often compromised in war. Very little is known about continuation and switching of contraceptive methods in these settings. An evaluation (...) of a contraceptive services program in North Kivu, Democratic Republic of the Congo (DRC) was conducted to measure 12-month contraceptive continuation by type of contraceptive method (short-acting or long-acting).A stratified systematic sample of women who initiated a contraceptive method 12-18 months prior to data collection was selected retrospectively from facility registers. A total of 548 women was interviewed about their contraceptive use: 304 who began a short-acting method (pills, injectables) and 244

2017 PLoS ONE

48. Integration of contraceptive services into anticoagulation management services improves access to long-acting reversible contraception. Full Text available with Trip Pro

Integration of contraceptive services into anticoagulation management services improves access to long-acting reversible contraception. Integration of services is a promising way to improve access to contraception in sub-Saharan Africa, but few studies have evaluated this strategy to increase access to contraception among women requiring anticoagulation. Our objective was to evaluate a model of care integrating contraceptive counseling and provision within an anticoagulation management clinic (...) in Eldoret, Kenya, to determine the impact on long-acting reversible contraception (LARC) use.We performed a prospective observational study of reproductive-age women referred for integrated services from the anticoagulation management clinic at Moi Teaching and Referral Hospital from March 2015 to March 2016. All participants received disease-specific contraceptive counseling and provision, free reversible methods (excluding hormonal intrauterine devices [IUDs]) and follow-up care. We compared LARC use

2018 Contraception

49. Role of Bridge Contraception in Postpartum Long-Acting Reversible Contraception and Sterilization Fulfillment Rates. Full Text available with Trip Pro

Role of Bridge Contraception in Postpartum Long-Acting Reversible Contraception and Sterilization Fulfillment Rates. To estimate the association of bridge contraception with interval long-acting reversible contraception (LARC) and sterilization fulfillment rates.This is a secondary analysis of a retrospective single-center cohort chart review study examining 1,851 postpartum women who requested LARC or sterilization after discharge. Bridge contraception was requested by 597 of these women (...) , 95% CI 0.95-1.05; adjusted OR 0.96, 95% CI 0.73-1.26).Bridge contraception is associated with increased LARC and sterilization fulfillment after postpartum discharge. Long-acting reversible contraception or sterilization fulfillment after discharge occurred in less than one in four women. Strategies to improve provision of LARC or sterilization before hospital discharge are necessary.

2018 Obstetrics and Gynecology

50. Contraception for women aged over 40 years.

) is a highly effective long-acting reversible contraceptive (LARC) method without hormones or their related side effects; some women may prefer the Cu-IUD for these reasons. The 52 mg levonorgestrel intrauterine system (LNG-IUS) offers very significant non-contraceptive benefits. It has been shown to be highly effective in reducing menstrual blood loss. It will also reduce pain associated with primary menstrual pain, endometriosis and adenomyosis. An IUS can also be an effective medical treatment (...) Contraception for women aged over 40 years. Contraception for women aged over 40 years. | National Guideline Clearinghouse success fail JUN 09 2017 2018 2019 14 Apr 2018 - 12 Jul 2018 COLLECTED BY Organization: Formed in 2009, the Archive Team (not to be confused with the archive.org Archive-It Team) is a rogue archivist collective dedicated to saving copies of rapidly dying or deleted websites for the sake of history and digital heritage. The group is 100% composed of volunteers and interested

2017 National Guideline Clearinghouse (partial archive)

51. Adolescent Pregnancy, Contraception, and Sexual Activity

, Sonfield A, Zolna MR, Finer LB. Return on investment: a fuller assessment of the benefits and cost savings of the US publicly funded family planning program. Milbank Q 2014;92:696–749. [ ] [Full Text] Frost JJ, Frohwirth L, Zolna MR. Contraceptive needs and services, 2014 update. New York (NY): Guttmacher Institute; 2016. Available at: . Retrieved January 4, 2017. Ricketts S, Klingler G, Schwalberg R. Game change in Colorado: widespread use of long-acting reversible contraceptives and rapid decline (...) of contraception over another. Dual method use—the use of condoms in combination with more effective contraceptive methods to protect against sexually transmitted infections and unwanted pregnancy—is the ideal contraceptive practice for adolescents. Just as adolescents should have access to the full range of contraceptives, including long-acting reversible contraceptive methods, they should be able to decline and discontinue any method on their own, without barriers. A reproductive justice framework

2017 American College of Obstetricians and Gynecologists

52. Counseling Adolescents About Contraception

care services vary by state, and obstetrician–gynecologists should be familiar with the regulations that apply to their practice. Emergency contraception routinely should be included in discussions about contraception, including access issues. The American College of Obstetricians and Gynecologists recommends that obstetrician–gynecologists write advance prescriptions for oral emergency contraception for their patients. Long-acting reversible contraceptive (LARC) methods have higher efficacy (...) the most effective methods, resulting in lower pregnancy rates ( ). In the United States, approximately 4.3% of women aged 15–19 years who are currently using a method of contraception use a highly-effective LARC method (eg, intrauterine devices and the implant) ( ). Long-acting reversible contraceptive methods have higher efficacy, higher continuation rates, and higher satisfaction rates compared with short-acting contraceptives. Because LARC methods are safe, they are excellent contraceptive choices

2017 American College of Obstetricians and Gynecologists

53. Selected practice recommendations for contraceptive use

Selected practice recommendations for contraceptive use Third edition 2016 World Health Organization Department of Reproductive Health and Research Selected practice recommendations for contraceptive useWHO Library Cataloguing-in-Publication Data Selected practice recommendations for contraceptive use – 3rd ed. 1.Contraception – methods. 2.Contraceptive Agents, Female. 3.Contraceptives, Oral, Combined. 4.Intrauterine Devices. 5.Natural Family Planning Methods. 6.Vasectomy. 7.Practice Guideline (...) States Agency for International Development WHO World Health Organization 5Executive summary Introduction This document is part of the process for improving the quality of care in family planning. Specifically, it is one of two evidence-based cornerstones (guidance documents) of the World Health Organization’s (WHO’s) initiative to develop and implement family planning guidelines for national programmes. The first cornerstone, the Medical eligibility criteria for contraceptive use (MEC, now in its

2017 World Health Organisation Guidelines

54. Hormonal contraceptive eligibility for women at high risk of HIV

, hormonal contraceptives constitute a significant component of the contraceptive method mix and unintended pregnancy is a common threat to the well-being and lives of women and girls. A wide range of stakeholders were present at this meeting, and serving on the Guideline Development Group (GDG) was global representation from experts in family planning and HIV, representatives from affected populations, clinicians, epidemiologists, researchers, programme managers, policy-makers and guideline (...) characteristics. Known as the Medical eligibility criteria for contraceptive use (MEC), this guidance offers national family planning programmes a comprehensive set of recommendations on the safety of contraceptive methods (1). The MEC was conceived as a global normative reference for policy-makers and programme managers developing their national policies, programmes, protocols and Background guidelines, with the overarching goal of removing unnecessary medical barriers to contraception. For over 20 years

2017 World Health Organisation Guidelines

55. Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission. Full Text available with Trip Pro

Cervical and systemic concentrations of long acting hormonal contraceptive (LARC) progestins depend on delivery method: Implications for the study of HIV transmission. Progestin-only long-acting reversible contraceptives (LARCs) are increasingly popular among women seeking contraception; however, recent epidemiological studies suggest that systemically administered medroxyprogesterone acetate (MPA) may increase HIV acquisition. In order to determine the exact mechanisms underlying increases (...) in transmission specific to MPA use and to test safer, alternative contraceptive progestin types and delivery methods, in vitro modeling studies must be performed. To achieve this, it is imperative that accurate hormone concentrations be utilized when modeling progestin-mediated outcomes, as the down-stream effects are dose-dependent. The local concentrations of progestins to which the lower female genital tract tissues are exposed after initiation of LARCs are unknown, but they likely differ from peripheral

2019 PLoS ONE

56. Leveraging long acting reversible contraceptives to achieve FP2020 commitments in sub-Saharan Africa: The potential of implants. Full Text available with Trip Pro

Leveraging long acting reversible contraceptives to achieve FP2020 commitments in sub-Saharan Africa: The potential of implants. In developing regions, an estimated 214 million women have an unmet need for family planning. Reaching Family Planning 2020 (FP2020) commitments will require a shift in modern contraceptive promotion, including improved access to long-acting reversible contraceptives (LARCs). Until now, a lack of market data limited understanding of the potential of LARCs to increase (...) contraceptive access and choice.From 2015, the FPwatch Project conducted representative surveys in Ethiopia, Nigeria, and Democratic Republic of Congo (DRC) using a full census approach in selected administrative areas. In these areas, every public and private sector outlet with the potential to sell or distribute modern contraceptives was approached. In outlets with modern contraceptives, product audits and provider interviews assessed contraceptive market composition, market share, availability, price

2018 PLoS ONE

57. Long-acting reversible contraception use among residents in obstetrics/gynecology training programs Full Text available with Trip Pro

Long-acting reversible contraception use among residents in obstetrics/gynecology training programs The objective of the study was to estimate the personal usage of long-acting reversible contraception (LARC) among obstetrics and gynecology (Ob/Gyn) residents in the United States and compare usage between programs with and without a Ryan Residency Training Program (Ryan Program), an educational program implemented to enhance resident training in family planning.We performed a web-based, cross (...) -sectional survey to explore contraceptive use among Ob/Gyn residents between November and December 2014. Thirty-two Ob/Gyn programs were invited to participate, and 24 programs (75%) agreed to participate. We divided respondents into two groups based on whether or not their program had a Ryan Program. We excluded male residents without a current female partner as well as residents who were currently pregnant or trying to conceive. We evaluated predictors of LARC use using bivariate analysis

2017 Open access journal of contraception

58. Correlates of long-acting reversible contraception uptake among rural women in Guatemala. Full Text available with Trip Pro

Correlates of long-acting reversible contraception uptake among rural women in Guatemala. In many low-resource settings around the world utilization of long-acting reversible contraception (LARC) is low, in part due to access barriers. We sought to explore LARC utilization patterns as well as factors associated with LARC initiation by women seeking contraception in rural Guatemala from a program working to reduce contraception access barriers.We analyzed data from a program that provides family (...) planning in six remote, primarily indigenous, villages in Guatemala with limited access to alternative health services. Methods are free and delivered directly within villages by culturally competent providers. We conducted a retrospective chart review of all 288 women who initiated a contraceptive method over a 16-month period and conducted a logistic regression to obtain adjusted odds ratios (OR) for predictors of LARC uptake.Overall 79.2% of women elected a LARC method. More than half of women (49.8

2018 PLoS ONE

59. Immediate Postpartum Long-Acting Reversible Contraception

Immediate Postpartum Long-Acting Reversible Contraception Immediate Postpartum Long-Acting Reversible Contraception - ACOG Menu ▼ Immediate Postpartum Long-Acting Reversible Contraception Page Navigation ▼ Number 670, August 2016 (Reaffirmed 2018) Committee on Obstetric Practice The American College of Nurse–Midwives and the Society for Maternal–Fetal Medicine endorse this document. The American Academy of Family Physicians and the Association of Women’s Health, Obstetric and Neonatal Nurses (...) support this document. This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice in collaboration with committee members Ann E. Borders, MD, MSc, MPH and Alison M. Stuebe, MD, MSc, and reviewed by the Long-Acting Reversible Contraception Work Group. This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course

2016 American College of Obstetricians and Gynecologists

60. Clinical Challenges of Long-Acting Reversible Contraceptive Methods

Clinical Challenges of Long-Acting Reversible Contraceptive Methods Clinical Challenges of Long-Acting Reversible Contraceptive Methods - ACOG Menu ▼ Clinical Challenges of Long-Acting Reversible Contraceptive Methods Page Navigation ▼ Number 672, September 2016 (Reaffirmed 2019) Committee on Gynecologic Practice Long-Acting Reversible Contraception Work Group This Committee Opinion was developed by the American College of Obstetricians and Gynecologists’ Committee on Gynecologic Practice (...) and the Long-Acting Reversible Contraceptive Expert Work Group in collaboration with committee member David L. Eisenberg, MD, and Expert Work Group members Nichole Tyson, MD and Eve Espey, MD. This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed. Clinical Challenges of Long-Acting Reversible Contraceptive Methods ABSTRACT: Long-acting

2016 American College of Obstetricians and Gynecologists

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>